KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Co-Diagnostics (CODX) Intangibles (2021 - 2025)

Historic Intangibles for Co-Diagnostics (CODX) over the last 5 years, with Q3 2025 value amounting to $27.2 million.

  • Co-Diagnostics' Intangibles changed 0.0% to $27.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.2 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $27.2 million for FY2024, which is 0.0% changed from last year.
  • Latest data reveals that Co-Diagnostics reported Intangibles of $27.2 million as of Q3 2025, which was down 0.0% from $27.2 million recorded in Q2 2025.
  • Over the past 5 years, Co-Diagnostics' Intangibles peaked at $27.2 million during Q4 2021, and registered a low of $27.2 million during Q4 2021.
  • Moreover, its 5-year median value for Intangibles was $27.2 million (2021), whereas its average is $27.2 million.
  • Within the past 5 years, the most significant YoY rise in Co-Diagnostics' Intangibles was 0.0% (2022), while the steepest drop was 0.0% (2022).
  • Over the past 5 years, Co-Diagnostics' Intangibles (Quarter) stood at $27.2 million in 2021, then changed by 0.0% to $27.2 million in 2022, then changed by 0.0% to $27.2 million in 2023, then changed by 0.0% to $27.2 million in 2024, then changed by 0.0% to $27.2 million in 2025.
  • Its Intangibles stands at $27.2 million for Q3 2025, versus $27.2 million for Q2 2025 and $27.2 million for Q1 2025.